Could you please add PPHM's 11.31 mab to you “HCV: Most Likely to Succeed ~ 6. Early- and very-early-stage compounds that use a novel MoA.“ Although it's still being investigated preclinical for hiv, it does show signs to be broadly neutralizing. I would expect PPHM, or a potential partner, to study this as both a therapeutic and a vaccine for many viral types.